Sialic Acid Binding Ig-like Lectin 2
"Sialic Acid Binding Ig-like Lectin 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.
| Descriptor ID |
D051918
|
| MeSH Number(s) |
D12.776.395.550.200.810 D12.776.503.921.200 D12.776.543.550.200.810 D23.050.301.350.720
|
| Concept/Terms |
Sialic Acid Binding Ig-like Lectin 2- Sialic Acid Binding Ig-like Lectin 2
- Sialic Acid Binding Ig like Lectin 2
- CD22 Glycoprotein
- Glycoprotein, CD22
- Siglec-2
- Antigens, CD22
- CD22 Antigens
- B-Lymphocyte Cell Adhesion Molecule
- B Lymphocyte Cell Adhesion Molecule
- CD22 Antigen
- Antigen, CD22
|
Below are MeSH descriptors whose meaning is more general than "Sialic Acid Binding Ig-like Lectin 2".
Below are MeSH descriptors whose meaning is more specific than "Sialic Acid Binding Ig-like Lectin 2".
This graph shows the total number of publications written about "Sialic Acid Binding Ig-like Lectin 2" by people in this website by year, and whether "Sialic Acid Binding Ig-like Lectin 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sialic Acid Binding Ig-like Lectin 2" by people in Profiles.
-
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S6-13.
-
A reevaluation of CD22 expression in human lung cancer. Cancer Res. 2014 Jan 01; 74(1):263-71.
-
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia. Cancer. 2013 Aug 01; 119(15):2728-36.
-
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. Lancet Oncol. 2012 Apr; 13(4):403-11.
-
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia. Br J Haematol. 2011 Aug; 154(4):471-6.
-
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 01; 26(22):3756-62.
-
CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype. Arch Pathol Lab Med. 2003 May; 127(5):561-6.
-
Conjunctival cytologic features of primary Sj?gren's syndrome. Ophthalmology. 1990 Aug; 97(8):985-91.